SIMPLE AND PRECISE UV SPECTROPHOTOMETRIC METHOD DEVELOPMENT FOR ESTIMATION OF ALBENDAZOLE FOR DISSOLUTION STUDY
Abstract
Albendazole is a class II drug in biopharmaceutical classification system, so its dissolution study is very difficult because of its low solubility and difficulty during estimation of drug in bulk. The present study deals with UV spectrophotometric method development and validation for estimation of albendazole in bulk form. Albendazole is a benzimidazole derivative with an oral broad spectrum of activity against human and animal helminthes parasites. The drug obeyed the Beer’s law and showed good correlation. It showed absorption maxima at 229nm in 0.1 N HCL with 0.05% sodium lauryl sulphate (SLS). The linearity was observed between 4-20μg/ml. The method was applied for the analysis of the drug in the pure, tablet and suspension forms. The slope and intercept of the equation of the regression line are 0.009 and 0.017 respectively. Correlation coefficient was found to be 0.9996. The results of analysis were validated by recovery studies. The recovery was more than 97%. The method was found to be simple, reliable, rapid, precise, specific and reproducible and can be applied for routine analysis of albendazole in different dosage form and dissolution studies.
Keywords:
Albendazole, UV-Vis Spectrophotometer, Recovery, ValidationDOI
https://doi.org/10.25004/IJPSDR.2015.070122References
2. Jaime ND, William AR. Textbook of organic medicinal and Pharmaceutical chemistry 10th Edition, Lippincolt Paven Publishers, Philadelhia , New-York, 1998, pp. 235-252.
3. International Pharmacopoeia. W.H.O. Volume 1, 3rd Edition, C.B.S. Publisher and distributors, India, 1987, pp. 130.
4. Rang HB, Dale MM, Rither JM: Pharmacology. 4th Edition. Churchill Livingstone. 1999, pp. 725-731.
5. Bar-Maor JA, DE Carvalho JL, Chapell J. Gastrografine treatment of intestinal obstruction due to ascaris lumbricoidei. J Pedia'r Surg. 1984; 19(2): 174-76.
6. Mir IA, Wani NA, Patnaik R. Albendazole therapy in ascariasis. JK science 2003; 5(4): 161-62.
7. Dayan AD. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta trop 2003; 86(2-3): 141-59.
8. The European Agency for the Evaluation of Medical/Products. ICH Topic Q2BNote for Guideline on Validation of Analytical Procedures: Methodology GPMP/ICH/281/95, 1996.
9. ICH draft Guidelines on Validation of Analytical Procedures: Definitions and Terminology, Federal Register, 60, IFPMA, Switzerland, 1995:1260.
10. Bolton S, In: Pharmaceutical Statistics: Practical and clinical application, 3rd ed. Marcel Dekker, New York 1997, pp. 216–264.
11. Miller JC, Miller JN. In: Statistics for analytical chemistry, 2nd ed, Wiley, New York, 1984, pp. 83-117.
12. Mohite AH, Peepliwal A, Development of UV-spectroscopic method for Nabumetone in Tablet formulation. J. Pharm. Research 2009; (2):1221-1223.
13. Shah R, Magdum C, Patil SK, Validated spectroscopic method for estimation of Aceclofenac from Tablet formulation. Research J. Pharm. and Tech. 1: 2008, 430.
Published
Abstract Display: 837 
PDF Downloads: 502 
